Skip to content

Regional Central Database Recording of Chronic Myeloid Leukemia

Regional Central Database Recording of Chronic Myeloid Leukemia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02869256
Acronym
LMC
Enrollment
400
Registered
2016-08-16
Start date
2014-01-31
Completion date
2024-01-31
Last updated
2017-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Myeloid Leukemia

Keywords

chronic myeloid leukemia, practices evaluation

Brief summary

It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.

Detailed description

Given the complexity and evolution of recommendations and to harmonize these, it appears necessary to establish a central database for recording , monitoring patients with CML supported by the participating centers the region and evaluation of care practices in use . Indeed , the main purpose of this database is to provide diagnostic and therapeutic management of reported cases of chronic myeloid leukemia and to study the prognostic factors . The main objective is to improve significantly the percentage of patients treated adequately load in the region, in the initial stages of the disease and during its evolution.

Interventions

OTHERPractices evaluation

Practices evaluation

Sponsors

Institut Bergonié
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* chronic myeloid leukemia Diagnosis (CML) in chronic phase , accelerated or blast * male or female patient aged 18 years or more * Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information * Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
compliance of the management of patients with chronic myeloid leukemia compared to the guidelines10 years

Secondary

MeasureTime frame
overall survival10 years

Countries

France

Contacts

Primary ContactGabriel etienne, MD
G.Etienne@bordeaux.unicancer.fr
Backup ContactSimone Mathoulin-Pelissier, MD PhD
S.Mathoulin@bordeaux.unicancer.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026